Depigmentation is the complete loss of color in the skin, caused by the destruction or absence of melanocytes, the cells responsible for producing pigment. Unlike hypopigmentation, where skin simply becomes lighter, depigmentation results in patches or areas that are entirely white, with no melanin remaining at all. The distinction matters because the causes, progression, and management differ significantly between the two.
How Depigmentation Differs From Hypopigmentation
The key difference is total versus partial pigment loss. In depigmentation, melanocytes are either destroyed or completely non-functional, leaving skin with zero melanin. In hypopigmentation, melanocytes are still present but underperforming, so the skin appears lighter than surrounding areas but retains some color.
Dermatologists distinguish the two using a Wood’s lamp, which emits ultraviolet light. Fully depigmented skin fluoresces a striking, sharply defined blue-white under this light because there is no melanin to absorb the UV. Hypopigmented skin, by contrast, shows only a dull, off-white glow. This simple exam can quickly clarify what’s happening beneath the surface and point toward the right diagnosis.
What Happens Inside the Skin
Melanocytes sit in the bottom layer of your epidermis and produce melanin, the pigment that gives skin, hair, and eyes their color. When something destroys these cells or stops them from working, the affected patch of skin turns white. In the most studied form of depigmentation, vitiligo, the process unfolds in stages.
First, oxidative stress builds up inside melanocytes. Excess reactive oxygen species damage the cells’ internal structures and cause them to malfunction. This stress also exposes proteins on the melanocyte surface that the immune system recognizes as foreign. The body’s own immune cells, specifically a type of killer T cell, then attack and destroy the melanocytes. This autoimmune assault accounts for the majority of melanocyte death in vitiligo. Once those cells are gone, the skin in that area can no longer produce pigment.
Melanocytes can also be destroyed through chemical exposure, genetic conditions, or physical trauma to the skin. The end result is the same: no pigment-producing cells, no color.
Common Causes of Depigmentation
Vitiligo
Vitiligo is the most recognized cause of depigmentation. It’s an autoimmune condition that can appear at any age and affects all skin types. The white patches often start small and may spread over time to cover large areas of the body. People with vitiligo are more likely to have other autoimmune conditions, including thyroid disorders, alopecia areata, type 1 diabetes, and pernicious anemia.
Chemical Leukoderma
Certain chemicals can directly destroy melanocytes on contact, producing white patches that may look identical to vitiligo. The first documented cases appeared in 1939 among workers at a leather factory who wore rubber gloves containing an antioxidant called monobenzyl ether of hydroquinone. Since then, dozens of chemicals have been linked to occupational depigmentation, primarily phenol and catechol derivatives found in rubber manufacturing, industrial cleaners, adhesives, and even some hair dyes. Para-phenylenediamine (PPD), a common ingredient in permanent hair color, was first linked to chemical leukoderma in 1993. Other triggers include certain skin-lightening products containing hydroquinone, some topical medications, and germicidal detergents.
Age-Related Pigment Loss
Idiopathic guttate hypomelanosis produces small, round white spots, typically 2 to 5 millimeters across, that appear on sun-exposed skin as people age. While technically classified as hypopigmentation rather than full depigmentation, these spots are extremely common: 87% of people over 40 have at least one, and up to 80% of people over 70 are affected. The spots are harmless and don’t spread or change, which distinguishes them from vitiligo.
Genetic Conditions
Albinism represents a different pathway to pigment loss. Rather than melanocyte destruction, people with albinism have melanocytes that cannot produce melanin properly due to inherited genetic defects. This results in very light or absent pigmentation from birth across the entire body.
Sun Exposure and Skin Without Pigment
Melanin acts as a natural sunscreen, absorbing UV radiation before it can damage skin cell DNA. Areas of depigmented skin have no melanin at all, making them extremely vulnerable to sunburn and long-term UV damage. People with very little epidermal melanin already face elevated skin cancer risk. Those with loss-of-function variants in key pigmentation genes have up to a four-fold increased lifetime risk of melanoma and other skin cancers. For anyone with depigmented patches, consistent sun protection on those areas, including high-SPF sunscreen, clothing coverage, and shade, is essential to prevent burns and reduce cumulative UV damage over time.
How Depigmentation Is Treated
Treatment depends entirely on the cause and on whether the goal is to restore color or to even out the skin by removing remaining pigment.
Restoring Pigment
For vitiligo, a newer class of topical medications that block specific immune pathways (JAK inhibitors) has shown meaningful results. In pooled clinical trial data, about 30% of patients using a topical JAK inhibitor achieved at least 75% repigmentation on the face, compared to 8% in the placebo group. When oral versions of these medications are combined with UV light therapy, average repigmentation reaches roughly 64%. These treatments work best when started earlier and on certain body areas, particularly the face and neck, which tend to respond better than hands and feet.
Surgical options exist for people with stable vitiligo that hasn’t spread in at least a year. Melanocyte transplantation procedures take pigment-producing cells from normally pigmented skin and transfer them to white patches. Success rates vary: one study found 57% of patients achieved repigmentation, while another reported that 85% of patients reached greater than 75% color return over nine months.
Intentional Depigmentation
For people with vitiligo covering more than 50% of their body, the opposite approach sometimes makes more sense: removing the remaining pigment to achieve a uniform appearance. The FDA-approved treatment for this is a 20% monobenzone cream, which permanently destroys melanocytes in the treated areas. This is specifically indicated only for extensive vitiligo and is not approved for cosmetic lightening, melasma, freckles, or any other pigmentation concern. The depigmentation it produces is permanent and irreversible.
Diagnosis Beyond the Surface
Because many conditions produce lighter skin, accurate diagnosis is important. A Wood’s lamp exam is often the first step, allowing a dermatologist to distinguish between true depigmentation and partial pigment loss. Vitiligo produces sharply defined blue-white fluorescence. Conditions like nevus depigmentosus or the ash-leaf spots seen in tuberous sclerosis appear as a duller off-white, indicating that some melanin remains.
The differential diagnosis for white spots on the skin is broad. Pityriasis versicolor (a fungal infection), pityriasis alba (common in children with eczema), post-inflammatory hypopigmentation (lightening after a skin injury or rash), and lichen sclerosus can all create lighter patches that mimic early depigmentation. The pattern of the spots, their location, whether they’re spreading, and how they look under UV light all help narrow the diagnosis. In cases where vitiligo is confirmed, screening for associated autoimmune conditions, particularly thyroid disease, is typically recommended.